ENDOCRINE-METABOLIC EFFECTS OF ASTHMA TREATMENT: The Impact of Glucocorticoid Therapy in the Elderly

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Immunology and Allergy Clinics of North America

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0889-8561(05)70338-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of spacers to facilitate inhaled corticosteroid treatment of asthma.

  2015cited by this paper
• Glucocorticoid-induced osteoporosis

  1999cited by this paper
• Pharmacokinetics and pharmacodynamics of inhaled corticosteroids.

  1998cited by this paper
• Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.

  1997cited by this paper
• How should inhaled glucocorticoids be compared?

  1997cited by this paper
• Clinical epidemiology and osteoporosis. Measures and their interpretation.

  1997cited by this paper
• The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation.

  1997cited by this paper
• Glucocorticoid replacement therapy: are patients over treated and does it matter?

  1997cited by this paper
• Bisphosphonates: preclinical aspects and use in osteoporosis.

  1997cited by this paper
• When your patient is hospitalized: tips for primary care physicians.

  1997cited by this paper
• Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota.

  1997cited by this paper
• How general practitioners manage acute asthma attacks.

  1997cited by this paper
• A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.

  1997cited by this paper
• The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.

  1997cited by this paper
• Prevalence of Inhaled Corticosteroid Use among Patients with Chronic Obstructive Pulmonary Disease: A Survey

  1997cited by this paper
• Editorial: Inertia in Clinical Research.

  1996cited by this paper
• Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.

  1996cited by this paper
• Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

  1996cited by this paper
• Testosterone therapy in glucocorticoid-treated men.

  1996cited by this paper
• Aerosol delivery systems for bronchial asthma.

  1996cited by this paper
• Osteoporosis in steroid-dependent asthma.

  1996cited by this paper
• Corticosteroid Usage: Observations at a Community Hospital

  1996cited by this paper
• Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.

  1996cited by this paper
• Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids.

  1996cited by this paper
• Molecular mechanisms of steroid action in asthma.

  1996cited by this paper
• Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.

  1996cited by this paper
• Efficacy and Cost Benefit of Inhaled Corticosteroids in Patients Considered to Have Mild Asthma in Primary Care Practice

  1996cited by this paper
• Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

  1996cited by this paper
• Glucocorticoids induced down‐regulation of glucocorticoid receptor mRNA expression in asthma

  1996cited by this paper
• Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.

  1996cited by this paper
• Diabetes management during glucocorticoid therapy for nonendocrine disease.

  1996cited by this paper
• Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

  1996cited by this paper
• Bone Density in Asthmatic Patients Taking Inhaled Corticosteroids: Comparison of Budesonide and Beclomethasone Dipropionate

  1996cited by this paper
• Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

  1996cited by this paper
• Calcium and Vitamin D3 Supplementation Prevents Bone Loss in the Spine Secondary to Low-Dose Corticosteroids in Patients with Rheumatoid Arthritis

  1996cited by this paper
• Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study.

  1996cited by this paper
• Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device.

  1996cited by this paper
• Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.

  1996cited by this paper
• FLUTICASONE PROPIONATE REDUCES ORAL PREDNISONE USE WHILE IT IMPROVES ASTHMA CONTROL*

  1996cited by this paper
• A bioassay for topical and systemic effect of three inhaled corticosteroids

  1995cited by this paper
• Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels.

  1995cited by this paper
• Effect of early vs late intervention with inhaled corticosteroids in asthma.

  1995cited by this paper
• Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.

  1995cited by this paper
• Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide.

  1995cited by this paper
• Nontapering versus tapering prednisone in acute exacerbations of asthma: a pilot trial.

  1995cited by this paper
• Diabetes mellitus in the elderly.

  1995cited by this paper
• Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.

  1995cited by this paper
• Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids.

  1995cited by this paper
• Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.

  1995cited by this paper
• Osteoporosis. Clinical features, prevention, and treatment.

  1995cited by this paper
• Estimating the Risk of Fracture in Osteopenic Patients

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy.

  1995cited by this paper
• Inhaled corticosteroids and bone density.

  1995cited by this paper
• Inhaled glucocorticoids for asthma.

  1995cited by this paper
• Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma.

  1995cited by this paper
• Diabetes in the Elderly

  1995cited by this paper
• Budesonide treatment of moderate and severe asthma in children: a dose-response study.

  1995cited by this paper
• Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

  1995cited by this paper
• Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids.

  1994cited by this paper
• Glucocorticoids and the risk for initiation of hypoglycemic therapy.

  1994cited by this paper
• Aging and hypothalamic-pituitary-adrenal response to challenge in humans.

  1994cited by this paper
• Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells.

  1994cited by this paper
• Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.

  1994cited by this paper
• Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.

  1994cited by this paper
• Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids.

  1994cited by this paper
• Perioperative Glucocorticoid Coverage A Reassessment 42 Years After Emergence of a Problem

  1994cited by this paper
• Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.

  1994cited by this paper
• The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932.

  1994cited by this paper
• The overnight single‐dose metyrapone test is a simple and reliable index of the hypothalamic‐pituitary‐adrenal axis

  1994cited by this paper
• Glucocorticoids and osteoporosis.

  1994cited by this paper
• A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma

  1994cited by this paper
• Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate.

  1994cited by this paper
• Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.

  1994cited by this paper
• The cluster phenomenon in patients who have multiple vertebral compression fractures.

  1993cited by this paper
• Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.

  1993cited by this paper
• Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates.

  1993cited by this paper
• Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis

  1993cited by this paper
• Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.

  1993cited by this paper
• Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

  1993cited by this paper
• Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.

  1993cited by this paper
• Verbal Learning and/or Memory Improves with Glycemic Control in Older Subjects with Non‐Insulin‐Dependent Diabetes Mellitus

  1993cited by this paper
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

  1993cited by this paper
• Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults

  1993cited by this paper
• Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma.

  1993cited by this paper
• Clinical Investigations: Asthma: Clinical Trial: Comparative Study: Journal Article: Multicenter Study: Randomized Controlled Trial: Research Support, Non-U.S. Gov'tA Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma

  1993cited by this paper
• Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis.

  1992cited by this paper
• An economic evaluation of asthma in the United States.

  1992cited by this paper
• Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate.

  1992cited by this paper
• Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids.

  1992cited by this paper
• Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.

  1992cited by this paper
• Guidelines For The Diagnosis And Management Of Asthma

  1992cited by this paper
• Estrogen and progesterone replacement therapy reduces glucocorticoid‐induced bone loss

  1992cited by this paper
• Highdose inhaled steroid therapy and the cortisol stress response to acute severe asthma

  1992cited by this paper
• Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.

  1992cited by this paper
• Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 μg triamcinolone acetonide

  1992cited by this paper
• High‐dose inhaled steroids in the management of asthma A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function

  1992cited by this paper
• Book Review Principles and Practice of Endocrinology and Metabolism Edited by Kenneth L. Becker, with eight others. 1912 pp., illustrated. Philadelphia, J.B. Lippincott, 1990. $125.

  1991cited by this paper
• Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin.

  1991cited by this paper
• Glucocorticoid therapy for asthma: clinical pharmacology.

  1991cited by this paper

• Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.

  2004cites this paper
• Influencia de los glucocorticoides inhalados sobre la densidad mineral ósea y el metabolismo óseo

  2000cites this paper